Truist cuts Public Service Enterprise stock price target on regulatory uncertainty

Truist cut its Public Service Enterprise Group price target to $78 from $84 and maintained a Hold rating, citing ongoing New Jersey and PJM regulatory processes that could extend into 2027. Truist estimates Q3 EPS of $1.18 and 2026 EPS of $4.37, within PSEG’s $4.28–$4.40 guidance range. In Q2 2026, PSEG’s non-GAAP operating EPS of $0.86 beat the $0.83 estimate, but revenue of $2.55 billion missed the $2.73 billion projection; management reaffirmed full-year guidance.

Analysis

PEG’s key risk is not the lowered target itself but the duration of regulatory uncertainty: delayed New Jersey and PJM decisions can defer clarity on rate-base growth and leave the market less willing to pay for its investment program. A year-end rate-case filing is the nearest company-specific catalyst; the phase 2 New Jersey report in early 2027 extends the resolution window. The Salem uprate could create customer-contract upside, but the 112-MW share is only an opportunity until counterparties, pricing, and timing are disclosed. CEG’s announcement may raise expectations for nuclear contracting across the sector, yet it does not establish equivalent economics for PEG.

Near term, the article’s hot-inflation/Fed-hike framing is a headwind for long-duration utility valuations if Treasury yields rise; it is a macro overlay, not evidence about UBS’s operating outlook. Over 1–3 months, monitor PEG’s rate-case details and PJM/FERC milestones. Over 6–18 months, regulatory outcomes and whether nuclear capacity secures bankable contracts matter more than quarter-to-quarter EPS beats. The contrarian case is that trading near its 52-week low may already reflect some uncertainty, while guidance was reaffirmed; however, the supplied information does not establish a valuation discount or quantify regulatory upside. No high-conviction directional trade is warranted without rate-case economics and nuclear-contract terms.

Key Decisions for Investors

• Keep PEG exposure neutral rather than adding on the target cut alone. Reassess after the year-end rate-case filing; verify requested ROE, rate base, capex recovery, and expected decision timetable.
• For a near-term portfolio hedge, consider a modest XLU put spread only if the hot-inflation signal is confirmed by rising Treasury yields; avoid treating one inflation print as a durable rate regime change. The hedge thesis weakens if yields reverse lower.
• Track any PEG disclosure on Salem uprate customer contracts alongside CEG’s nuclear contracting activity. Treat this as a watch item—not an earnings catalyst—until pricing, customer commitment, and timing are confirmed.
• Falsify the cautious PEG view if the rate filing supports timely recovery and management maintains or raises its earnings outlook; downside risk increases if regulatory delays persist, guidance is cut, or long-term yields rise materially.